OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · IEX Real-Time Price · USD
2.17
+0.05 (2.36%)
At close: Aug 8, 2022 3:59 PM
2.19
+0.02 (0.69%)
After-hours:
Aug 8, 2022 6:32 PM EDT
Income Statement (Trailing)
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Quarter Ending | 2021-09-30 | 2021-03-31 | 2020-03-31 |
|---|---|---|---|
| Selling, General & Admin
|
4.93 | 3.19 | 1.02 |
| Research & Development
|
0.62 | 0.17 | 0.52 |
| Operating Expenses
|
5.54 | 3.37 | 1.53 |
| Operating Income
|
-5.54 | -3.37 | -1.53 |
| Interest Expense / Income
|
0 | 0 | 0 |
| Other Expense / Income
|
-0.06 | 0.01 | 0.08 |
| Pretax Income
|
-5.49 | -3.38 | -1.62 |
| Income Tax
|
-0.21 | -0.02 | -0.08 |
| Net Income
|
-5.27 | -3.35 | -1.54 |
| Net Income Common
|
-5.27 | -3.35 | -1.54 |
| Shares Outstanding (Basic)
|
1,407 | 1,407 | - |
| EPS (Basic)
|
-0.65 | -0.65 | - |
| EPS (Diluted)
|
-0.65 | -0.65 | - |
| Free Cash Flow Per Share
|
-0.19 | -0.07 | - |
| Effective Tax Rate
|
3.90% | 0.74% | 4.71% |
| EBITDA
|
-5.46 | -3.37 | -1.61 |
| Depreciation & Amortization
|
0.03 | 0.01 | 0.01 |
| EBIT
|
-5.49 | -3.38 | -1.62 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).